Zibo Qianhui Biological Technology is a company operating in the pharmaceutical industry.
Founded in 2006 , Zibo Qianhui Biological Technology Co., Ltd is a high-tech enterprise specialized in the fields of research, manufacturing and trade. Insisting on innovation-driven development strategy, Qianhui has launched series of cyclodextrin derivatives, such as Hydroxypropyl Beta Cyclodextrin, Betadex Sulfobutyl Ether Sodium, Methyl Beta Cyclodextrin, Gamma Cyclodextrin, Hydroxypropyl Gamma Cyclodextrin and so on. Stand century-old Qianhui, Do the best excipients is the eternal mission of Qianhui people!
Company type
Products and services
Excipients, Intermediates, Fine and Specialty Chemicals, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Zibo Qianhui Biological Technology, No. 3666 West Baoshan Road, High-tech District, Zibo, Shandong, China, 255000
Stay ahead of trends and best practices
